RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jointown Pharmaceutical Group Co - Stock

Jointown Pharmaceutical Group Co EBIT 2024

Jointown Pharmaceutical Group Co EBIT

4.93 B CNY

Ticker

600998.SS

ISIN

CNE100000W45

In 2024, Jointown Pharmaceutical Group Co's EBIT was 4.93 B CNY, a 18.35% increase from the 4.16 B CNY EBIT recorded in the previous year.

The Jointown Pharmaceutical Group Co EBIT history

YEAREBIT (undefined CNY)
2026e6.14
2025e5.5
2024e4.93
20234.16
20223.55
20213.19
20203.78
20193.31
20182.56
20172.1
20161.67
20151.3
20140.98
20130.81
20120.68
20110.53
20100.57
20090.43
20080.33
20070.25

Jointown Pharmaceutical Group Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jointown Pharmaceutical Group Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jointown Pharmaceutical Group Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jointown Pharmaceutical Group Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jointown Pharmaceutical Group Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jointown Pharmaceutical Group Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jointown Pharmaceutical Group Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jointown Pharmaceutical Group Co’s growth potential.

Jointown Pharmaceutical Group Co Revenue, Profit, and EBIT History

DateJointown Pharmaceutical Group Co RevenueJointown Pharmaceutical Group Co EBITJointown Pharmaceutical Group Co Net Income
2026e209.98 B CNY6.14 B CNY3.58 B CNY
2025e191.15 B CNY5.5 B CNY3.13 B CNY
2024e171.47 B CNY4.93 B CNY2.99 B CNY
2023150.14 B CNY4.16 B CNY2.17 B CNY
2022140.42 B CNY3.55 B CNY2.07 B CNY
2021122.41 B CNY3.19 B CNY2.44 B CNY
2020110.86 B CNY3.78 B CNY2.96 B CNY
201999.5 B CNY3.31 B CNY1.56 B CNY
201887.14 B CNY2.56 B CNY1.12 B CNY
201773.94 B CNY2.1 B CNY1.34 B CNY
201661.56 B CNY1.67 B CNY820 M CNY
201549.59 B CNY1.3 B CNY695 M CNY
201441.07 B CNY980 M CNY561 M CNY
201333.44 B CNY805 M CNY478 M CNY
201229.51 B CNY681 M CNY413 M CNY
201124.84 B CNY525 M CNY374 M CNY
201021.19 B CNY570 M CNY360 M CNY
200918.96 B CNY425 M CNY298 M CNY
200816.29 B CNY330 M CNY203 M CNY
200713.05 B CNY248 M CNY160 M CNY

Jointown Pharmaceutical Group Co stock margins

The Jointown Pharmaceutical Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jointown Pharmaceutical Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jointown Pharmaceutical Group Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jointown Pharmaceutical Group Co's sales revenue. A higher gross margin percentage indicates that the Jointown Pharmaceutical Group Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jointown Pharmaceutical Group Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jointown Pharmaceutical Group Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jointown Pharmaceutical Group Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jointown Pharmaceutical Group Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jointown Pharmaceutical Group Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jointown Pharmaceutical Group Co Margin History

Jointown Pharmaceutical Group Co Gross marginJointown Pharmaceutical Group Co Profit marginJointown Pharmaceutical Group Co EBIT marginJointown Pharmaceutical Group Co Profit margin
2026e8.02 %2.92 %1.71 %
2025e8.02 %2.88 %1.64 %
2024e8.02 %2.87 %1.74 %
20238.02 %2.77 %1.45 %
20227.76 %2.53 %1.48 %
20218.01 %2.61 %1.99 %
20208.94 %3.41 %2.67 %
20198.73 %3.32 %1.57 %
20188.62 %2.94 %1.29 %
20178.43 %2.84 %1.81 %
20167.83 %2.71 %1.33 %
20157.54 %2.61 %1.4 %
20147.08 %2.39 %1.37 %
20136.65 %2.41 %1.43 %
20126.34 %2.31 %1.4 %
20115.89 %2.11 %1.51 %
20106.43 %2.69 %1.7 %
20095.93 %2.24 %1.57 %
20085.51 %2.03 %1.25 %
20074.95 %1.9 %1.23 %

Jointown Pharmaceutical Group Co Aktienanalyse

What does Jointown Pharmaceutical Group Co do?

Jointown Pharmaceutical Group Co Ltd is a Chinese company specializing in the production and distribution of pharmaceuticals. The company was founded in 1999 in Wuhan and has since become a significant player in the pharmaceutical industry. The company's business model is based on the production and sale of generic drugs, which are cheaper alternatives to existing medications. This makes them more affordable for many people. Jointown Pharmaceuticals operates in various areas, with one of the main areas being the production of cancer drugs. The company manufactures a variety of cancer medications and is one of the leading manufacturers in China in this field. Jointown Pharmaceuticals is also active in other areas of medicine, such as producing medications for diabetes, infectious diseases, and cardiovascular diseases. The company offers a wide range of products, including generics, patented medications, medical devices, diagnostics, dietary supplements, and cosmetic products. Jointown Pharmaceuticals emphasizes close collaboration with scientific institutions and partnerships with foreign partners in order to drive the development of new products and expand internationally. Jointown is also active in Germany through its subsidiary, Jointown Europe GmbH. The company's history is marked by steady growth. Jointown Pharmaceuticals has become one of the leading pharmaceutical companies in China within a few years and has gained international recognition. In 2013, the company successfully went public, generating additional financial resources. In addition to its pharmaceutical business, Jointown Pharmaceuticals is also involved in social projects. The company contributes to the fight against poverty and diseases in China and prioritizes environmental protection and sustainability. Overall, Jointown Pharmaceuticals is an innovative and successful company in the pharmaceutical industry. Its focus on the production of generics contributes significantly to providing affordable medications to the population. The wide range of products and the close collaboration with international partners demonstrate a modern and globally oriented corporate culture. Jointown Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Jointown Pharmaceutical Group Co's EBIT

Jointown Pharmaceutical Group Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Jointown Pharmaceutical Group Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Jointown Pharmaceutical Group Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Jointown Pharmaceutical Group Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Jointown Pharmaceutical Group Co Stock

How much did Jointown Pharmaceutical Group Co achieve in EBIT for the current year?

In the current year, Jointown Pharmaceutical Group Co has achieved an EBIT of 4.93 B CNY.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Jointown Pharmaceutical Group Co.

How has the EBIT of Jointown Pharmaceutical Group Co developed in recent years?

The EBIT of Jointown Pharmaceutical Group Co has increased by 18.351% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Jointown Pharmaceutical Group Co?

The EBIT of Jointown Pharmaceutical Group Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Jointown Pharmaceutical Group Co pay?

Over the past 12 months, Jointown Pharmaceutical Group Co paid a dividend of 0.24 CNY . This corresponds to a dividend yield of about 4.77 %. For the coming 12 months, Jointown Pharmaceutical Group Co is expected to pay a dividend of 0.24 CNY.

What is the dividend yield of Jointown Pharmaceutical Group Co?

The current dividend yield of Jointown Pharmaceutical Group Co is 4.77 %.

When does Jointown Pharmaceutical Group Co pay dividends?

Jointown Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Jointown Pharmaceutical Group Co?

Jointown Pharmaceutical Group Co paid dividends every year for the past 6 years.

What is the dividend of Jointown Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0.24 CNY are expected. This corresponds to a dividend yield of 4.85 %.

In which sector is Jointown Pharmaceutical Group Co located?

Jointown Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jointown Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jointown Pharmaceutical Group Co from 6/7/2024 amounting to 0.25 CNY, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did Jointown Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 6/7/2024.

What was the dividend of Jointown Pharmaceutical Group Co in the year 2023?

In the year 2023, Jointown Pharmaceutical Group Co distributed 0.3 CNY as dividends.

In which currency does Jointown Pharmaceutical Group Co pay out the dividend?

The dividends of Jointown Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jointown Pharmaceutical Group Co

Our stock analysis for Jointown Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jointown Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.